Loading…
Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)
The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to e...
Saved in:
Published in: | Antioxidants 2020-10, Vol.9 (10), p.1020 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53 |
---|---|
cites | cdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53 |
container_end_page | |
container_issue | 10 |
container_start_page | 1020 |
container_title | Antioxidants |
container_volume | 9 |
creator | Hinarejos, Isabel Machuca, Candela Sancho, Paula Espinós, Carmen |
description | The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation. |
doi_str_mv | 10.3390/antiox9101020 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ac9fe3fff7084b0c9614b8aebba6b30b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ac9fe3fff7084b0c9614b8aebba6b30b</doaj_id><sourcerecordid>2454152643</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</originalsourceid><addsrcrecordid>eNpdks1v1DAQxSMEolXpkXskLkVqwB9xYl-QtoXCSqU9AGdr_LXrVWIXOyktf31dUiEWX8Z-7-k31miq6jVG7ygV6D2Eycc7gRFGBD2rDgnqu4YKgp__cz-ojnPeoXIEphyJl9UBpagYjB5Wv7_6KeptDCZ5GOqP99nNQRdqOK2v77yByd_a-tuUbM41BFNf2TlFH9wA4wiPudqHRTR2Y4NNi_jLT9v6LEEx16m8V1rP4zws5snV2Xr19lX1wsGQ7fFTPap-XHz6fv6lubz-vD5fXTa6ZXxqnHLKWKWQ6W1LmWK4M473mnGNOSFU9B3tEG-Baq6EIKIXpmOOMq0pOM3oUbVeuCbCTt4kP0K6lxG8_CPEtJGQJq8HK0ELZ6lzri9AhbTocKs4lO7QKYpUYX1YWDezGq3RNkwJhj3ovhP8Vm7irewZF5igAjh5AqT4c7Z5kqPP2g4DBBvnLEnLWsxI19ISffNfdBfnFMqoJGFtxzlhQpRUs6R0ijkn6_5-BiP5uCRyb0noA0dFsao</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2546882599</pqid></control><display><type>article</type><title>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Hinarejos, Isabel ; Machuca, Candela ; Sancho, Paula ; Espinós, Carmen</creator><creatorcontrib>Hinarejos, Isabel ; Machuca, Candela ; Sancho, Paula ; Espinós, Carmen</creatorcontrib><description>The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.</description><identifier>ISSN: 2076-3921</identifier><identifier>EISSN: 2076-3921</identifier><identifier>DOI: 10.3390/antiox9101020</identifier><identifier>PMID: 33092153</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Animal cognition ; Apoptosis ; Autophagy ; Basal ganglia ; Bioenergetics ; Biosynthesis ; brain iron accumulation ; Central nervous system diseases ; Choreoathetosis ; Disease ; Dystonia ; Enzymes ; Extrapyramidal system ; Genes ; Genetic screening ; Homeostasis ; Inflammation ; Iron ; Kinases ; Lipid metabolism ; Lipids ; Metabolism ; Metabolites ; Mitochondria ; mitochondrial dysfunction ; Movement disorders ; Mutation ; Neurodegeneration ; neurodegenerative disorder ; neuroinflammation ; Oxidative stress ; Phagocytosis ; Phenotypes ; Phosphorylation ; Proteins ; rare disease ; Review ; Triglycerides</subject><ispartof>Antioxidants, 2020-10, Vol.9 (10), p.1020</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</citedby><cites>FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</cites><orcidid>0000-0003-4435-1809 ; 0000-0002-8849-0213 ; 0000-0001-9548-4359 ; 0000-0003-3439-1831</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2546882599/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2546882599?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,75096</link.rule.ids></links><search><creatorcontrib>Hinarejos, Isabel</creatorcontrib><creatorcontrib>Machuca, Candela</creatorcontrib><creatorcontrib>Sancho, Paula</creatorcontrib><creatorcontrib>Espinós, Carmen</creatorcontrib><title>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</title><title>Antioxidants</title><description>The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.</description><subject>Animal cognition</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Basal ganglia</subject><subject>Bioenergetics</subject><subject>Biosynthesis</subject><subject>brain iron accumulation</subject><subject>Central nervous system diseases</subject><subject>Choreoathetosis</subject><subject>Disease</subject><subject>Dystonia</subject><subject>Enzymes</subject><subject>Extrapyramidal system</subject><subject>Genes</subject><subject>Genetic screening</subject><subject>Homeostasis</subject><subject>Inflammation</subject><subject>Iron</subject><subject>Kinases</subject><subject>Lipid metabolism</subject><subject>Lipids</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Mitochondria</subject><subject>mitochondrial dysfunction</subject><subject>Movement disorders</subject><subject>Mutation</subject><subject>Neurodegeneration</subject><subject>neurodegenerative disorder</subject><subject>neuroinflammation</subject><subject>Oxidative stress</subject><subject>Phagocytosis</subject><subject>Phenotypes</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>rare disease</subject><subject>Review</subject><subject>Triglycerides</subject><issn>2076-3921</issn><issn>2076-3921</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1v1DAQxSMEolXpkXskLkVqwB9xYl-QtoXCSqU9AGdr_LXrVWIXOyktf31dUiEWX8Z-7-k31miq6jVG7ygV6D2Eycc7gRFGBD2rDgnqu4YKgp__cz-ojnPeoXIEphyJl9UBpagYjB5Wv7_6KeptDCZ5GOqP99nNQRdqOK2v77yByd_a-tuUbM41BFNf2TlFH9wA4wiPudqHRTR2Y4NNi_jLT9v6LEEx16m8V1rP4zws5snV2Xr19lX1wsGQ7fFTPap-XHz6fv6lubz-vD5fXTa6ZXxqnHLKWKWQ6W1LmWK4M473mnGNOSFU9B3tEG-Baq6EIKIXpmOOMq0pOM3oUbVeuCbCTt4kP0K6lxG8_CPEtJGQJq8HK0ELZ6lzri9AhbTocKs4lO7QKYpUYX1YWDezGq3RNkwJhj3ovhP8Vm7irewZF5igAjh5AqT4c7Z5kqPP2g4DBBvnLEnLWsxI19ISffNfdBfnFMqoJGFtxzlhQpRUs6R0ijkn6_5-BiP5uCRyb0noA0dFsao</recordid><startdate>20201020</startdate><enddate>20201020</enddate><creator>Hinarejos, Isabel</creator><creator>Machuca, Candela</creator><creator>Sancho, Paula</creator><creator>Espinós, Carmen</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7T5</scope><scope>7TO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4435-1809</orcidid><orcidid>https://orcid.org/0000-0002-8849-0213</orcidid><orcidid>https://orcid.org/0000-0001-9548-4359</orcidid><orcidid>https://orcid.org/0000-0003-3439-1831</orcidid></search><sort><creationdate>20201020</creationdate><title>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</title><author>Hinarejos, Isabel ; Machuca, Candela ; Sancho, Paula ; Espinós, Carmen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animal cognition</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Basal ganglia</topic><topic>Bioenergetics</topic><topic>Biosynthesis</topic><topic>brain iron accumulation</topic><topic>Central nervous system diseases</topic><topic>Choreoathetosis</topic><topic>Disease</topic><topic>Dystonia</topic><topic>Enzymes</topic><topic>Extrapyramidal system</topic><topic>Genes</topic><topic>Genetic screening</topic><topic>Homeostasis</topic><topic>Inflammation</topic><topic>Iron</topic><topic>Kinases</topic><topic>Lipid metabolism</topic><topic>Lipids</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Mitochondria</topic><topic>mitochondrial dysfunction</topic><topic>Movement disorders</topic><topic>Mutation</topic><topic>Neurodegeneration</topic><topic>neurodegenerative disorder</topic><topic>neuroinflammation</topic><topic>Oxidative stress</topic><topic>Phagocytosis</topic><topic>Phenotypes</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>rare disease</topic><topic>Review</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hinarejos, Isabel</creatorcontrib><creatorcontrib>Machuca, Candela</creatorcontrib><creatorcontrib>Sancho, Paula</creatorcontrib><creatorcontrib>Espinós, Carmen</creatorcontrib><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Antioxidants</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hinarejos, Isabel</au><au>Machuca, Candela</au><au>Sancho, Paula</au><au>Espinós, Carmen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</atitle><jtitle>Antioxidants</jtitle><date>2020-10-20</date><risdate>2020</risdate><volume>9</volume><issue>10</issue><spage>1020</spage><pages>1020-</pages><issn>2076-3921</issn><eissn>2076-3921</eissn><abstract>The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>33092153</pmid><doi>10.3390/antiox9101020</doi><orcidid>https://orcid.org/0000-0003-4435-1809</orcidid><orcidid>https://orcid.org/0000-0002-8849-0213</orcidid><orcidid>https://orcid.org/0000-0001-9548-4359</orcidid><orcidid>https://orcid.org/0000-0003-3439-1831</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2076-3921 |
ispartof | Antioxidants, 2020-10, Vol.9 (10), p.1020 |
issn | 2076-3921 2076-3921 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ac9fe3fff7084b0c9614b8aebba6b30b |
source | Publicly Available Content Database; PubMed Central |
subjects | Animal cognition Apoptosis Autophagy Basal ganglia Bioenergetics Biosynthesis brain iron accumulation Central nervous system diseases Choreoathetosis Disease Dystonia Enzymes Extrapyramidal system Genes Genetic screening Homeostasis Inflammation Iron Kinases Lipid metabolism Lipids Metabolism Metabolites Mitochondria mitochondrial dysfunction Movement disorders Mutation Neurodegeneration neurodegenerative disorder neuroinflammation Oxidative stress Phagocytosis Phenotypes Phosphorylation Proteins rare disease Review Triglycerides |
title | Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T03%3A57%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20Dysfunction,%20Oxidative%20Stress%20and%20Neuroinflammation%20in%20Neurodegeneration%20with%20Brain%20Iron%20Accumulation%20(NBIA)&rft.jtitle=Antioxidants&rft.au=Hinarejos,%20Isabel&rft.date=2020-10-20&rft.volume=9&rft.issue=10&rft.spage=1020&rft.pages=1020-&rft.issn=2076-3921&rft.eissn=2076-3921&rft_id=info:doi/10.3390/antiox9101020&rft_dat=%3Cproquest_doaj_%3E2454152643%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2546882599&rft_id=info:pmid/33092153&rfr_iscdi=true |